This dual role has been investigated in trials, supporting the notion that GM-CSF is a valuable tool in immunosuppressive status due to sepsis by reversing disease severity, as marked by mHLA-DR expression enhancement and cytokine release [5,52], even though it may not be offered in recovery at the stage of severe sepsis [53]. This evidence concerns the gene CSF2 and Sepsis.